Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BlackRock Inc. CPF Central Pacific Financial Corp 13G/A 14.6% 2y
JPMORGAN CHASE & CO PMVP PMV Pharmaceuticals, Inc. 13G/A 7.1% 2y
JPMORGAN CHASE & CO PPLI People Inc 13G/A 7% 2y
JPMORGAN CHASE & CO III Information Services Group Inc. 13G/A 5.3% 2y
JPMORGAN CHASE & CO NXPI NXP Semiconductors N.V. 13G/A 10.1% 2y
JPMORGAN CHASE & CO EXAS EXACT SCIENCES CORP 13G/A 9.5% 2y
JPMORGAN CHASE & CO OM Outset Medical, Inc. 13G/A 9.4% 2y
JPMORGAN CHASE & CO HLMN Hillman Solutions Corp. 13G/A 5.3% 2y
JPMORGAN CHASE & CO L Loews Corp 13G/A 5.9% 2y
JPMORGAN CHASE & CO NTRA Natera, Inc. 13G/A 6.6% 2y
JPMORGAN CHASE & CO LASR Nlight, Inc. 13G/A 7.5% 2y
T.I.I. - JETSERVICES, LDA NTRB NutriBand Inc. 13D 15.92% 2y
Merck & Co., Inc. EVAX Evaxion A/S 13G 11.4% 2y
CD&R BOULDER HOLDINGS, L.P. BECN Beacon Roofing Supply, Inc. 13D/A 0% 2y
CANNELL CAPITAL LLC LEE LEE ENTERPRISES, Inc 13G 9.45% 2y
SCOPIA CAPITAL MANAGEMENT LP HLIT Harmonic Inc. 13D/A 3.9% 2y
Adimab, LLC IVVD Invivyd, Inc. 13D/A 19.7% 2y
STILWELL JOSEPH PFBX Peoples Financial Corp 13D/A 12.7% 2y
Joseph D. Samberg NN Nextnav Inc. 13G/A 10.7% 2y
Bluescape Energy Partners IV GP LLC FEAM 5E Advanced Materials, Inc. 13D/A 37.6% 2y
BRC Group Holdings, Inc. BW Babcock & Wilcox Enterprises, Inc. 13D/A 32.4% 2y
Phillip Frost, M.D. OPK Opko Health, Inc. 13D/A 33.9% 2y
EW Healthcare Partners, L.P. VERO Venus Concept Inc. 13D/A 50.9% 2y
BCLS I Investco, LP PHVS Pharvaris N.V. 13G/A 3.8% 2y
PAULSON & CO. INC. THM International Tower Hill Mines Ltd 13D/A 32.1% 2y
HELU CARLOS SLIM TALO Talos Energy Inc. 13D 22.6% 2y
Yoda PLC CCEC Capital Clean Energy Carriers Corp. 13D/A 23.5% 2y
Jianhui Ye EZGO EZGO Technologies Ltd. 13D/A 6.58% 2y
Exor N.V. STLA Stellantis N.V. 13D/A 14.9% 2y
Arena Capital Advisors, LLC- CA HCVI Hennessy Capital Investment Corp. VI Class A Common Stock 13G/A 0% 2y
Leviticus Partners LP HBIO Harvard Bioscience Inc 13G/A 4.94% 2y
Madison Avenue Partners, LP CEE Central & Eastern Europe Fund, Inc. 13G 5.9% 2y
Dapice Joshua J. ELEV Elevation Oncology, Inc. Common stock 13G 7.3% 2y
ARGOS SEM, LLC SUM Summit Materials, Inc. Class A Common Stock 13D 31.4% 2y
BAYVIEW ASSET MANAGEMENT, LLC GHLD Guild Holdings Company 13G 5.9% 2y
Paradigm Biocapital Advisors LP TARS Tarsus Pharmaceuticals, Inc. 13G 5.8% 2y
Dustin Shindo HOVR New Horizon Aircraft Ltd. 13D 33% 2y
Ming Ni MATH Metalpha Technology Holding Ltd 13D/A 4.2% 2y
Artal Participations S.a r.l SLDB Solid Biosciences Inc. 13G 7.3% 2y
SZOP Multistrat LP PRLH Pearl Holdings Acquisition Corp Class A Ordinary Shares 13G 13.7% 2y
Logos Global Management LP ELEV Elevation Oncology, Inc. Common stock 13G 8.6% 2y
Harraden Circle Investments, LLC TVGN Tevogen Inc. 13G 5.62% 2y
STATE STREET CORP MDGL Madrigal Pharmaceuticals, Inc. 13G/A 3.55% 2y
BlackRock Inc. AVAV AeroVironment Inc 13G/A 16% 2y
BlackRock Inc. SMTC Semtech Corp 13G/A 16.1% 2y
BlackRock Inc. STAA Staar Surgical Co 13G/A 16.7% 2y
STATE STREET CORP UGI Ugi Corp 13G/A 4.91% 2y
BlackRock Inc. WGO Winnebago Industries Inc 13G/A 16.2% 2y
BlackRock Inc. OSG Octave Specialty Group Inc 13G/A 16.1% 2y
BlackRock Inc. TMHC Taylor Morrison Home Corp 13G/A 14.8% 2y